Nghĩa của từ pharmacokinetic bằng Tiếng Việt
xem pharmacokinetics
Đặt câu có từ "pharmacokinetic"
1. Objective:To observe pharmacokinetic characteristics of desflurane during inhalation anesthesia.
2. Intravenous Apomorphine therapy in Parkinson's disease: clinical and pharmacokinetic observations
3. • Pharmacokinetic study regarding use of existing capsules (new adjunctive therapy)
4. Metoprolol did not alter the pharmacokinetic profile of venlafaxine or its active metabolite, O-desmethylvenlafaxine
5. Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers
6. The pharmacokinetic profile showed serum levels sufficient to provide good antimicrobial activity throughout the dosing interval.
7. In the absence of pharmacokinetic interaction studies, alli is not recommended to be used by patients receiving acarbose
8. Thus, the intrinsic pharmacokinetic properties of glulisine are closely aligned with the physiologic release of insulin.
9. These ADME process parameters can then be integrated into so called "physiologically based pharmacokinetic models" or PBPK.
Các thông số quá trình ADME này sau đó có thể được tích hợp vào cái gọi là "mô hình dược động học dựa trên sinh lý học" hoặc PBPK.
10. Additional pharmacokinetic studies may be required to establish dosage regimens according to certain population variables
11. Additional pharmacokinetic studies may be required to establish dosage regimens according to certain population variables.
12. Abstract: articlethe first to study on pharmacokinetic and eliminate of OTC in turbot after oral administration.
13. Acarbose In the absence of pharmacokinetic interaction studies, the concomitant administration of orlistat with acarbose should be avoided
14. Population pharmacokinetic analyses of demographic data indicate that no dose adjustments are necessary for weight or ECOG score
15. Evidence of adequate exposure may be derived from pharmacokinetic data (ICH Guidance on Repeated Dose Tissue Distribution Studies).
16. The pharmacokinetic profile of AVONEX has been investigated indirectly with an assay that measures interferon antiviral activity
17. Different quantification techniques such as the use of a cutoff line, time dependent and pharmacokinetic assessment were comparatively evaluated.
18. Children The pharmacokinetics of oseltamivir have been evaluated in single-dose pharmacokinetic studies in children aged # to # years
19. Renagel is not absorbed from the gastrointestinal tract according to a single dose pharmacokinetic study in healthy volunteers
20. Pharmacokinetic interaction studies in postmenopausal women have demonstrated the absence of any interaction potential with tamoxifen or hormone replacement therapy (oestrogen
21. A large intra- and interindividual variation is found, as reported in all previous pharmacokinetic studies of the different 5-ASA formulations.
22. In a population pharmacokinetic analysis, creatinine clearance was found to be a statistically significant covariate affecting the oral clearance of ambrisentan
23. Bionomics Limited (ASX: BNO, OTCQB: BNOEF, Germany: AU000000BNO5), a global, clinical stage biopharmaceutical company, today announced positive pharmacokinetic (PK) results from a …
24. Objective: We compared the pharmacokinetic exposure following a single subcutaneous dose of benralizumab 30 mg using either autoinjectors (AI) or Accessorized prefilled syringes (APFS)
25. The present animal study was designed to investigate the pharmacokinetic behavior of epinephrine after endobronchial (e.b.) and intravenous (i.v.) administration and its correlation to pharmacodynamic measurements.
26. The legislative background for Coccidiostats as feed additives or anticoccidial drugs in the European Union (EU) is presented; pharmacokinetic profile and residues depletion are highlighted.
27. This analysis suggests that dose adjustment of rituximab with any of the tested covariates is not expected to result in a meaningful reduction in its pharmacokinetic variability
28. Bioavailability (how completely the drug is absorbed from its dosage form) and pharmacokinetic studies in animals and humans also have become important to include in a drug development plan
29. By the GM pharmacokinetic analysis, it suggested that the accumulation of drugs in perilymph be a key point of GM ototoxicity by the disturbance of the blood-labyrinth barrier.
30. Based on the 3-amide benzoic acid scaffold reported by our group previously, a series of 5-Aryl-3-amide benzoic acid derivatives were designed as novel P2Y 14 antagonists with improved pharmacokinetic properties.
31. The processed EEG with the median frequency, spectral edge frequency or bispectral index are important scientific tools to quantify central anaesthetic effects especially to develop pharmacodynamic- pharmacokinetic models of anaesthetic action.
32. Bionomics Limited (ASX:BNO) (OTCQB:BNOEF) Executive Chairman Errol De Souza tells Proactive tells Proactive the Adelaide, Australia- based biopharmaceutical company has received positive pharmacokinetic results from a 7-day dosing study to treat PTSD, using its new formulation of BNC210
33. The processed EEG and the derived parameters MF and SEF are important scientific tools to quantify central effects of many anaesthetics and opioid analgesics that allow the development of pharmacodynamic-pharmacokinetic models of anaesthetic action.
34. In the population pharmacokinetic analysis of the phase # studies, the effect of the most frequently used concomitant medicinal products in patients with psoriasis (including paracetamol, ibuprofen, acetylsalicylic acid, metformin, atorvastatin, levothyroxine) on pharmacokinetics of ustekinumab was explored
35. In vivo Bioavailability studies are performed for new drug to establish essential pharmacokinetic parameters including rate of absorption, extent of absorption, rates of excretion and metabolism and elimination half-life after a single and multiple dose administration
36. The transfer of a pharmacon between two compartments of a pharmacokinetic model as a function of time up to now could be evaluated only by differential calculus (Laplace transformation) with the help of complicated algebraic manipulation or by mechanical means.
37. Beneficial pharmacokinetic interactions include the improvement of the bioavailability of a drug (i.e., by enhancing absorption and/or inhibiting metabolism) or prolongation of a drug's plasma level within its therapeutic window (i.e., by decreasing excretion), whereas Beneficial pharmacodynamic interactions include additive or synergistic effects.
38. Aromatase inhibitors is that covalent binding of the drug to the active site of the enzyme irreversibly inhib - its Aromatase action.12,13 However, exemestane has not been used in pediatrics, except for one pharmacokinetic study.29 Nonsteroidal Aromatase inhibitors form a rever - sible bond with the enzyme
39. The chondrometabolic, Antireactive and antiarthritis properties of this form have been investigated extensively and are supported by controlled clinical trials 2; Pharmacokinetic studies revealed that close to 90% of orally administered glucosamine sulfate is absorbed 3; Glucosamine sulfate, in vivo, breaks down into glucosamine and sulfate ions.
40. Regarding the question of Absorbability of CS and its molecule size, please consider these references summarized here: "Pharmacokinetic studies performed on humans and experimental animals after oral administration of chondroitin sulfate revealed that it can be absorbed orally.Chondroitin sulfate shows first-order kinetics up to single doses of 3,000 mg
41. Indeed, physiologically based pharmacokinetic modelling predicts that concentrations of cyanoethylene oxide in the brains of humans would be considerably greater than those in rats exposed to similar concentrations of acrylonitrile, although increases in brain cancer have not been observed in epidemiological studies with limited power to detect excesses of this rare tumour.
42. Although specific interaction studies were not conducted for all medicinal products, population pharmacokinetic analysis showed no effect of concomitant medication on sildenafil pharmacokinetics when grouped as CYP#C# inhibitors (such as tolbutamide, warfarin, phenytoin), CYP#D# inhibitors (such as selective serotonin reuptake inhibitors, tricyclic antidepressants), thiazide and related diuretics, loop and potassium sparing diuretics, angiotensin converting enzyme inhibitors, calcium channel blockers, beta-adrenoreceptor antagonists or inducers of CYP# metabolism (such as rifampicin, barbiturates